Medical and Scientific Meetings
Staff members from the Pancreatic Cancer Action Network attend and participate in a number of medical and scientific meetings throughout the year. On this page you will find summaries of educational information from various meetings. This information is intended to summarize a selection of sessions.
January 22-24, 2010
Select Pancreatic Cancer Sessions
Detailed summaries are downloadable
in pdf format.
IV - Prevention, Screening and Diagnosis
role of Octreotide Imaging in Detecting Neuroendocrine Tumors (NETs) in
2010: Do we still need it?
V – Translational Research
Delivery in Pancreatic Cancer
VI – Multidisciplinary Treatment
Results of the Phase III Trial of Sunitinib Versus Placebo for the Treatment
of Advanced Pancreatic Neuroendocrine Tumors
I study of MK-0646 (dalotuzumab), a Humanized Monoclonal Antibody Against
IGF-1R in Combination with Gemcitabine or Gemcitabine plus Erlotinib for
Advanced Previously Untreated Pancreatic Cancer
Phase II Trial of Induction Cetuximab, Gemcitabine and Oxaliplatin Followed
by Radiotherapy with Concurrent Capecitabine and Cetuximab for Locally
Advanced Pancreatic Adenocarcinoma
The information and services
provided by the Pancreatic Cancer Action Network, Inc. are for informational
purposes only. The information and services are not intended to
be substitutes for professional medical advice, diagnosis or treatment.
If you are ill, or suspect that you are ill, see a doctor immediately!
The Pancreatic Cancer Action Network does not recommend nor endorse any
specific physicians, products or treatments even though they may be mentioned
on this site. 100316